Henry Schein earnings were $398.0M for the trailing 12 months ending Dec 27, 2025, with 7.2% growth year over year. The latest HSIC earnings report on Dec 27, 2025 announced Q4 2025 earnings of $101.0M, up 0% from last quarter. For the last reported fiscal year 2025 ending Dec 27, 2025, HSIC reported annual earnings of $398.0M, with 2.1% growth.
HSIC past earnings growth
How has HSIC's earnings growth performed historically?
On HSIC's earnings call on Invalid Date, Henry Schein (NASDAQ: HSIC) reported Q4 2025 earnings per share (EPS) of $0.85, up 13.33% year over year. Total HSIC earnings for the quarter were $101.00 million. In the same quarter last year, Henry Schein's earnings per share (EPS) was $0.75.
As of the last Henry Schein earnings report, Henry Schein is currently profitable. Henry Schein's net profit (also called net income) for the twelve months ending Dec 27, 2025 was $398.00 million, a 2.05% increase year over year.
What was HSIC's earnings growth in the past year?
As of Henry Schein's earnings date in Invalid Date, Henry Schein's earnings has grown 7.17% year over year. This is 31.88 percentage points lower than the US Medical Distribution industry earnings growth rate of 39.04%. HSIC earnings in the past year totalled $398.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.